RhumbLine Advisers’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$649K Sell
49,716
-1,904
-4% -$24.8K ﹤0.01% 2505
2025
Q1
$769K Sell
51,620
-1,949
-4% -$29K ﹤0.01% 2301
2024
Q4
$973K Sell
53,569
-18,168
-25% -$330K ﹤0.01% 2264
2024
Q3
$964K Sell
71,737
-37,202
-34% -$500K ﹤0.01% 2283
2024
Q2
$1.51M Sell
108,939
-3,287
-3% -$45.5K ﹤0.01% 2026
2024
Q1
$2.1M Buy
112,226
+1,801
+2% +$33.7K ﹤0.01% 1891
2023
Q4
$2.5M Buy
110,425
+4,560
+4% +$103K ﹤0.01% 1800
2023
Q3
$2.62M Sell
105,865
-1,809
-2% -$44.8K ﹤0.01% 1728
2023
Q2
$3.02M Sell
107,674
-4,176
-4% -$117K ﹤0.01% 1681
2023
Q1
$2.5M Buy
111,850
+4,455
+4% +$99.4K ﹤0.01% 1691
2022
Q4
$2.85M Sell
107,395
-524
-0.5% -$13.9K ﹤0.01% 1605
2022
Q3
$3.06M Buy
107,919
+1,594
+1% +$45.2K ﹤0.01% 1527
2022
Q2
$2.22M Buy
106,325
+4,031
+4% +$84K ﹤0.01% 1712
2022
Q1
$2.22M Buy
102,294
+2,556
+3% +$55.4K ﹤0.01% 1761
2021
Q4
$2.77M Sell
99,738
-6,277
-6% -$174K ﹤0.01% 1711
2021
Q3
$2.25M Sell
106,015
-12,859
-11% -$273K ﹤0.01% 1847
2021
Q2
$1.96M Sell
118,874
-6,499
-5% -$107K ﹤0.01% 1958
2021
Q1
$1.57M Buy
125,373
+1,321
+1% +$16.5K ﹤0.01% 2012
2020
Q4
$1.1M Buy
124,052
+12,854
+12% +$114K ﹤0.01% 2090
2020
Q3
$722K Sell
111,198
-26,643
-19% -$173K ﹤0.01% 2122
2020
Q2
$849K Buy
137,841
+1,951
+1% +$12K ﹤0.01% 2111
2020
Q1
$916K Buy
135,890
+6,341
+5% +$42.7K ﹤0.01% 1916
2019
Q4
$1.51M Buy
129,549
+6,228
+5% +$72.4K ﹤0.01% 1904
2019
Q3
$1.27M Buy
123,321
+5,379
+5% +$55.4K ﹤0.01% 1930
2019
Q2
$1.11M Buy
117,942
+10,297
+10% +$96.6K ﹤0.01% 2018
2019
Q1
$757K Buy
107,645
+1,685
+2% +$11.9K ﹤0.01% 2152
2018
Q4
$777K Buy
105,960
+17,899
+20% +$131K ﹤0.01% 2118
2018
Q3
$769K Sell
88,061
-1,383
-2% -$12.1K ﹤0.01% 2112
2018
Q2
$1.01M Buy
89,444
+4,305
+5% +$48.4K ﹤0.01% 2008
2018
Q1
$946K Buy
85,139
+913
+1% +$10.1K ﹤0.01% 1968
2017
Q4
$1.08M Buy
84,226
+12,621
+18% +$161K ﹤0.01% 1914
2017
Q3
$1.02M Buy
71,605
+4,242
+6% +$60.4K ﹤0.01% 1964
2017
Q2
$870K Buy
67,363
+4,191
+7% +$54.1K ﹤0.01% 2015
2017
Q1
$907K Buy
63,172
+17,988
+40% +$258K ﹤0.01% 1981
2016
Q4
$705K Buy
45,184
+2,445
+6% +$38.1K ﹤0.01% 2035
2016
Q3
$503K Sell
42,739
-2,380
-5% -$28K ﹤0.01% 2199
2016
Q2
$628K Sell
45,119
-2,325
-5% -$32.4K ﹤0.01% 2054
2016
Q1
$552K Buy
47,444
+3,310
+7% +$38.5K ﹤0.01% 2161
2015
Q4
$723K Buy
44,134
+2,820
+7% +$46.2K ﹤0.01% 2018
2015
Q3
$562K Buy
41,314
+1,634
+4% +$22.2K ﹤0.01% 2148
2015
Q2
$503K Sell
39,680
-10,000
-20% -$127K ﹤0.01% 2324
2015
Q1
$589K Buy
49,680
+3,000
+6% +$35.6K ﹤0.01% 2196
2014
Q4
$583K Buy
46,680
+3,700
+9% +$46.2K ﹤0.01% 2188
2014
Q3
$399K Hold
42,980
﹤0.01% 2358
2014
Q2
$280K Buy
42,980
+2,510
+6% +$16.4K ﹤0.01% 2644
2014
Q1
$327K Sell
40,470
-1,330
-3% -$10.7K ﹤0.01% 2485
2013
Q4
$417K Sell
41,800
-2,750
-6% -$27.4K ﹤0.01% 2365
2013
Q3
$270K Sell
44,550
-954
-2% -$5.78K ﹤0.01% 2605
2013
Q2
$235K Buy
+45,504
New +$235K ﹤0.01% 2861